Bank of Montreal Can lessened its holdings in Cartesian Growth Co. II (NASDAQ:RENE – Get Rating) by 30.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 150,000 shares of the company's stock after selling 65,858 shares during the quarter. Bank of Montreal Can's holdings in Cartesian Growth Co. II were worth $1,539,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the business. Virtu Financial LLC purchased a new position in Cartesian Growth Co. II in the third quarter valued at $112,000. Captrust Financial Advisors purchased a new position in Cartesian Growth Co. II in the third quarter valued at $194,000. Ergoteles LLC purchased a new position in Cartesian Growth Co. II in the third quarter valued at $300,000. Wolverine Asset Management LLC acquired a new position in Cartesian Growth Co. II in the fourth quarter valued at $690,000. Finally, Context Capital Management LLC acquired a new position in Cartesian Growth Co. II in the third quarter valued at $1,006,000. Hedge funds and other institutional investors own 59.40% of the company's stock.
Get Cartesian Growth Co. II alerts:Cartesian Growth Co. II Stock Performance
NASDAQ RENE opened at $10.52 on Wednesday. Cartesian Growth Co. II has a 1 year low of $9.90 and a 1 year high of $11.20. The company has a fifty day moving average of $10.47 and a two-hundred day moving average of $10.30.
Cartesian Growth Co. II Profile
(Get Rating)
Cartesian Growth Corporation II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.
Featured Articles
- Get a free copy of the StockNews.com research report on Cartesian Growth Co. II (RENE)
- United Parcel Service Delivers A Warning To The Market
- Pulte Homes Is Hosting The Better, More Profitable Open House
- Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal
- A Top Is In For McDonald's Corporation Stock
- Strong Demand Makes Cleveland-Cliffs an Undervalued Mid-Cap
Want to see what other hedge funds are holding RENE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cartesian Growth Co. II (NASDAQ:RENE – Get Rating).
Receive News & Ratings for Cartesian Growth Co. II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cartesian Growth Co. II and related companies with MarketBeat.com's FREE daily email newsletter.